abstract |
The present invention relates to a chimeric mouse-human antibody for the treatment of amyloid deposition diseases, pharmaceutical compositions comprising the antibody, methods and materials for producing the antibody, and methods for treating amyloid deposition disease at the using the antibody and the pharmaceutical composition. |